Issue |
E3S Web Conf.
Volume 319, 2021
International Congress on Health Vigilance (VIGISAN 2021)
|
|
---|---|---|
Article Number | 01067 | |
Number of page(s) | 8 | |
DOI | https://doi.org/10.1051/e3sconf/202131901067 | |
Published online | 09 November 2021 |
Antibacterial power of Olea Europaea extracts from different Moroccan regions
1 Laboratory of Epidemic Diseases, Department of Medical Bacteriology, National Institute of Hygiene, Avenue Ibn Batouta, Rabat, Morocco
2 Laboratory of Biology and Health, Department of Biology, Faculty of Science, Ibn Tofail University, Kenitra, Morocco
The discovery of antibiotics has always been a medical advance that has improved the prognosis of infections. However, resistance to these products has evolved into a major health problem. Some diseases are even resistant to all antibiotics currently available on the market. A reduction in the use of antibiotics must be based on other approaches, namely the use of alternative treatments to antibiotics, such as phytotherapy. In the same objective our study focused on the research of the antibacterial power of Olea Europaea known for its various medicinal properties. 31 bacterial strains were tested for their susceptibility using the agar diffusion method, and we determined their MIC by the micro titration technique on microplates. Five bacteria belonged to the American collection (ATCC) and 26 strains isolated from nosocomial infections between the period of 2011 and 2015. We noticed that our aqueous, methanolic, ethanolic and ethyl acetate extracts are active against all tested bacteria. On the other hand, we observed that the hexane and dichloromethane extracts showed no inhibition effect on all the bacteria tested. The methanolic extract showed a higher MIC against ESBL enterobacteria (E. coli, E. cloacae, P. mirabilis) and imipenem-resistant A. baumanii. The lowest MIC was 1.56 ug / ml.
Key words: antibiotic resistance / antibacterial activity / Olea Europaea / medicinal plants
© The Authors, published by EDP Sciences, 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.